During the opening lecture at the International Conference on Advanced Technologies & Treatments for Diabetes, Melanie Davies, CBE, MB, ChB, MD, FRCP, FRCGP, professor of diabetes medicine at the University of Leicester and an honorary consultant diabetologist at the University Hospitals of Leicester NHS Trust, reviewed how GLP-1 receptor agonists such as semaglutide (Ozempic/Wegovy, Novo Nordisk) have changed the way providers approach the treatment of type 2 diabetes and obesity and discussed some of the medications that combine GLP-1 with other molecules
207 9195 10.1016/j.taap.2005.02.028 [DOI] [PubMed] [Google Scholar] Samudio I., Konopleva M., Hail N., Jr., Shi Y
This is a Compounded Medication Prepared for Patient-Specific use Pursuant to an Individual Prescription
Provides hydration and antioxidant protection throughout the day
The subject's pre-treatment timed-trial was 57:30 (minutes:seconds)
Key Features: Effortless Pull-On Application: With an easy pull-on design and adjustable pressure straps above and below the kneecap, this brace ensures a secure, custom fit that stays in place throughout your day
